Saillant Therapeutics
PrivateCompany Overview
Saillant Therapeutics is a biotechnology company that develops small molecule-based therapies for the treatment of heart failure, Alzheimer's disease, and viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
small moleculedrug discoverypreclinical developmentbiotechtherapeutic candidateslicensingtissue regenerationviral replicationdrug pipelinebiotech startupdrug licensingcellular master regulatorspreclinical assets
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saillant Therapeutics Comparables
Compare Saillant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GliaPharm SA | 83% | |
| Cornovus Pharmaceuticals Inc. | 74% | |
| HAYA Therapeutics | 70% | |
Saillant Therapeutics Funding Rounds
Historical fundraising activity
Saillant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stichting RedMedTech Discovery Fund | Debt |
Saillant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Saillant Therapeutics's valuation, stock price, and market status.